At Investor Conferences

Advertisement

Picture [iito] Back into Ad 650x80px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in France and Monaco or involving organisations from these countries.

Total search results: 1888 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Enthera–SEVERAL: investment, 202007 financing round Series A €28m co-led by Sofinnova Partners + AbbVie Ventures 2020-07-28
Enthera–Sofinnova: investment, 202007 financing round Series A totalling €28m incl existing + co-lead investor Sofinnova Partners 2020-07-28
Tubulis–BPCE: investment, 202007 financing round Series A totalling €10.7m incl co-investor Seventure Partners 2020-07-21
Tubulis–SEVERAL: investment, 202007 financing round Series A €10.7m co-led by BioMedPartners + HTGF 2020-07-21
Enancio–Illumina: acquisition, 202007 acquisition of Enancio by Illumina 2020-07-14
Osivax–Trophic Communications: public relations, 202007 service existent by Trophic Communications 2020-07-08
Sanofi–Kiadis: NK cell therapy, 202007– license ww excl for K-NK004 program + two other programs €17.5m upfront + €857.5m milestones + royalties 2020-07-08
Citryll–BPCE: investment, 202007 financing round Series A totalling €18.5m incl new + lead investor Seventure incl its Health for Capital II fund 2020-07-02
Citryll–SEVERAL: investment, 202007 financing round Series A €18.5m led by Seventure + co-led by BioGeneration Ventures 2020-07-02
Lysogene–Weizmann Institute: gene therapy, 202007– collab research + license option AAV gene therapy for Gaucher + Parkinson diseases 2020-07-01
Resolution Spectra Systems–Merck (DE): investment, 202007 acquisition €na of Resolution Spectra Systems by Merck 2020-07-01
Enterome–BPCE: investment, 202006 financing round Series E €na incl existing investor Seventure Health for Life Capital 2020-06-25
Enterome–Nestlé: investment, 202006 financing round Series E €na incl existing investor Nestlé Health Science 2020-06-25
Enterome–Omnes Capital: investment, 202006 financing round Series E €na incl existing investor Omnes Capital 2020-06-25
Enterome–Principia SGR: investment, 202006 financing round Series E €na incl existing investor Principia 2020-06-25
Enterome–SEVERAL: investment, 202006 financing round Series E €na with existing plus new investors SymBiosis LLC + Takeda Pharma 2020-06-25
Enterome–SymBiosis LLC: investment, 202006 financing round Series E €na incl new investor SymBiosis LLC 2020-06-25
Enterome–Takeda: investment, 202006 financing round Series E €na incl new investor Takeda Pharmaceutical Co Ltd 2020-06-25
RareCyte–Scienion: single-cell dispenser, 202006 supply existent of cellenONE to RareCyte for CTC analysis technology by Cellenion 2020-06-22
DiogenX–Advent France Biotechnology: investment, 202006 seed financing round totalling €4.5m incl investor Advent France Biotechnology 2020-06-16
DiogenX–Andrew Lloyd Associates: public relations, 202006 service existent by ALA 2020-06-16
DiogenX–Boehringer: investment, 202006 seed financing round totalling €4.5m incl investor BIVF 2020-06-16
DiogenX–Juvenile Diabetes Research Foundation: investment, 202006 seed financing round totalling €4.5m incl investor JDRF T1D Fund 2020-06-16
DiogenX–SEVERAL: investment, 202006 seed financing round €4.5m from Advent France Biotechnology + BIVF + JDRF T1D Fund 2020-06-16
eTheRNA–BNP Paribas: investment, 202006 financing round Series B totalling €34m incl new investor BNP Paribas Fortis Equity 2020-06-16
MedinCell–SEVERAL: investment, 202006 capital increase €15.6m from French + international investors 2020-06-16
Ona Therapeutics–France (govt): investment, 202006 financing round Series A totalling €30m incl new investor Bpifrance InnoBio 2 2020-06-16
Ona Therapeutics–SEVERAL: investment, 202006 financing round Series A €30m 2020-06-16
Epsilen Bio–Sofinnova: investment, 202006c seed financing €2.3m from Sofinnova Partners through Sofinnova Telethon Fund 2020-06-15
Corvidia Therapeutics–Novo Group: investment, 202006 acquisition $725m upfront cash + $1.375b milestones cash by Novo Nordisk ANNOUNCED 2020-06-11
Bioqube Ventures–Belgium (govt): investment, 202006 first closing totalling €60m of Bioqube Factory Fund I incl investor Belfius Insurance 2020-06-10
Bioqube Ventures–Belgium (govt): investment, 202006 first closing totalling €60m of Bioqube Factory Fund I incl investor FPIM 2020-06-10
Bioqube Ventures–EU (govt): investment, 202006 first closing totalling €60m of Bioqube Factory Fund I incl investor EIF 2020-06-10
Bioqube Ventures–Flanders (govt): investment, 202006 first closing totalling €60m of Bioqube Factory Fund I incl investor PMV 2020-06-10
Bioqube Ventures–Genmab: investment, 202006 first closing totalling €60m of Bioqube Factory Fund I incl strategic investor Genmab 2020-06-10
Bioqube Ventures–JnJ: investment, 202006 first closing totalling €60m of Bioqube Factory Fund I incl strategic investor JnJ Innovation 2020-06-10
Bioqube Ventures–Molenwater Groep: investment, 202006 first closing totalling €60m of Bioqube Factory Fund I incl investor Molenwater Groep 2020-06-10
Bioqube Ventures–SEVERAL: investment, 202006 first closing €60m of Bioqube Factory Fund I investors incl EIF + PMV + FPIM + Genmab + JJDC et al 2020-06-10
Protera–SEVERAL: investment, 202006 financing round Series A $5.6m led by Sofinnova Partners + incl existing investor SOSV 2020-06-10
NodThera–SEVERAL: investment, 202006 financing round Series B £44m ($55m) led by Novo Ventures 2020-06-03
MedinCell–SEVERAL: credit, 202005– state guaranteed PGE loan €10.9m at 0.25% up to 5y from Banque Populaire du Sud + BNP Paribas 2020-05-27
Tollys–Andrew Lloyd Associates: public relations, 202005 service existent by ALA 2020-05-26
Tollys–SEVERAL: investment, 202005 financing round Series A €2.3m bringing total raised since founding 2015 to €6.4m 2020-05-26
Poxel–Trophic Communications: public relations, 202005 service existent IR+ media EU/US by Trophic Communications 2020-05-25
HotSpot Therapeutics–SEVERAL: investment, 202005 financing round Series B $65m led by SR One 2020-05-21
HotSpot Therapeutics–Sofinnova: investment, 202005 financing round Series B totalling $65m incl existing + co-investor Sofinnova Partners 2020-05-21
ElsaLys–Mediolanum: investment, 202005 acquisition of ElsaLys Biotech by Mediolanum Farmaceutici SpA 2020-05-07
Vaxxel–Transgene: cell line technology, 202005 acquisition €na of DuckCelt-T17 cell line from Transgene incl shareholding for Transgene 2020-05-04
Vaxxel–Transgene: investment, 202005 investment €na Transgene becomes shareholder as part of acquisition of DuckCelt-T17 cell line by Vaxxel 2020-05-04
Pfizer–Valneva: Lyme disese vaccine, 202004– collab developm of VLA15 + commerc by Pfizer $130m upfront + $178m milestones + 2-digit tiered royalties 2020-04-30
PinCell–SEVERAL: investment, 202004 seed financing round €1.65m led by Sofinnova Telethon Fund 2020-04-30
PinCell–Sofinnova: investment, 202004 seed financing round totalling €1.65m incl lead investor Sofinnova Telethon Fund 2020-04-30
Genespire–Sofinnova: investment, 202004 Series A financing €16m from Sofinnova Partners 2020-04-29
Kurma–EU (govt): investment, 202004 final closing of Kurma Biofund III totalling €160m incl investor EIF 2020-04-29
Kurma–Institut Pasteur: investment, 202004 final closing of Kurma Biofund III totalling €160m incl investor Pasteur Institute 2020-04-29
Kurma–North Rhine-Westphalia (govt): investment, 202004 final closing of Kurma Biofund III totalling €160m incl investor NRW.BANK 2020-04-29
Kurma–SEVERAL: investment, 202004 final closing of Kurma Biofund III with €160m 2020-04-29
MicroPort Scientific–Robocath: cardiovascular devices, 202004– collab strategic agreem to set up joint venture in China for vascular robotics platform 2020-04-29
Polyplus-transfection–Warburg Pincus: investment, 202004 investment resulting in Warburg Pincus + ArchiMed owning equal shares + voting rights 2020-04-29
Robocath–MicroPort Scientific: investment, 202004 financing round Series C totalling €40m incl new + lead investor MicroPort Scientific Corp 2020-04-29
Robocath–SEVERAL: investment, 202004 financing round Series C €40m led by MicroPort Scientific 2020-04-29
Gustave Roussy–Biognosys: MS-based proteomics, 202004– collab using proteomic profiling in attempt to repurpose tocilizumab for Covid-19 2020-04-28
BrainVectis–AskBio: investment, 202004 acquisition €na of BrainVectis by Asklepios BioPharmaceutical 2020-04-22
EnginZyme–SEVERAL: investment, 202004 financing round Series A €6.4m led by Sofinnova Partners 2020-04-22
EnginZyme–Sofinnova: investment, 202004 financing round Series A totalling €6.4m incl lead investor Sofinnova Industrial Biotech Fund 2020-04-22
Valneva–Dynavax: SARS-CoV-2 vaccine, 202004– collab development combining Valneva’s vaccine technology with adjuvant CpG 1018 of Dynavax 2020-04-22
LNC Therapeutics–Univ Valencia: microbiomic treatment, 202004– license ww excl for patent on Christensenella therapeutics for mood disorders 2020-04-15
Servier–Gorrissen Federspiel: legal services, 202004 supply service Gorrissen Federspiel legal advisor to Servier w regard to acquisition of Symphogen 2020-04-03
Servier–Lazard: financial services, 202004 supply service Lazard financial advisor to Servier w regard to acquisition of Symphogen 2020-04-03
Servier–McDermott Will & Emery: legal services, 202004 supply service MWE legal advisor to Servier w regard to acquisition of Symphogen 2020-04-03
Symphogen–Perkins Coie: legal services, 202004 supply service Perkins Coie legal advisor to Symphogen w regard to acquisition by Servier 2020-04-03
Symphogen–Plesner: legal services, 202004 supply service Plesner AP legal advisor to Symphogen w regard to acquisition by Servier 2020-04-03
Symphogen–Rothschild & Co: financial services, 202004 supply service Rothschild & Co financial advisor to Symphogen w regard to acquisition by Servier 2020-04-03
Symphogen–Servier: investment, 202004–202006 acquisition 100% €na 2020-04-03
Lysogene–OrbiMed: investment, 202003 capital increase totalling €7.7m incl €6.6m from new + lead investor OrbiMed Advisors LLC 2020-03-12
Lysogene–Sarepta: investment, 202003 capital increase totalling €7.7m incl €538k from existing + co-investor Sarepta Therapeutics 2020-03-12
Lysogene–SEVERAL: investment, 202003 capital increase €7.7m led by OrbiMed Advisors + incl Sarepta Therapeutics at €2.83/share 2020-03-12
Life Sciences Partners–BMS: investment, 202003 final closing totalling €600m of LSP 6 fund incl investor BMS 2020-03-10
Life Sciences Partners–EU (govt): investment, 202003 final closing totalling €600m of LSP 6 fund incl investor EIF 2020-03-10
Life Sciences Partners–Otsuka: investment, 202003 final closing totalling €600m of LSP 6 fund incl investor Otsuka Pharmaceutical 2020-03-10
Life Sciences Partners–SEVERAL: investment, 202003 final closing €600m of LSP 6 fund with investors incl BMS + Otsuka + EIF 2020-03-10
Calixar–SEVERAL: investment, 202003 second financing round €2.5m 2020-03-09
AstraZeneca–Voluntis: digital therapeutics, 202003 collab existent 2020-03-04
BMS–Voluntis: digital therapeutics, 202003–collab developm of digital therapeutics using Theraxium Oncology platform 2020-03-03
Ipsen–Genedata: bioinformatics, 202002 supply existent Ipsen is existing customer of Genedata 2020-02-26
Servier–Genedata: bioinformatics, 202002 supply existent Servier is existing customer of Genedata 2020-02-26
FinnGen–Sanofi: genomics, 202002 collab existent Sanofi is industry partner of Finnish genome research project FinnGen 2020-02-25
Scipio Bioscience–BPCE: investment, 202002 financing round Series A totalling €6m incl existing + co-investor Seventure Partners Quadrivium 1 Fund 2020-02-25
Scipio Bioscience–Financière Arbevel: investment, 202002 financing round Series A totalling €6m incl new + co-investor Financière Arbevel 2020-02-25
Scipio Bioscience–High-Tech Gründerfonds: investment, 202002 financing round Series A totalling €6m incl existing + co-investor HTGF 2020-02-25
Scipio Bioscience–Merck (DE): investment, 202002 financing round Series A totalling €6m incl lead investor M Ventures 2020-02-25
Scipio Bioscience–SEVERAL: investment, 202002 financing round Series A €6m led by M Ventures 2020-02-25
Scipio Bioscience–Verve Capital Partners: investment, 202002 financing round Series A totalling €6m incl new + co-investor investiere 2020-02-25
Servier–Cellectis: T-cell immunotherapy, 202002– collab amendment + expansion ww excl license to develop + commercialise UCARTs tageting CD19 2020-02-18
Apexbio/Cycloud–Stilla Technologies: digital PCR technology, 202002 distribution existent in China by Apexbio/Cycloud 2020-02-11
Stilla Technologies–BNP Paribas: investment, 202002 financing round Series B totalling €20m incl existing investor BNP Paribas Développement 2020-02-11
Stilla Technologies–Eurazeo: investment, 202002 financing round Series B totalling €20m incl existing investor Idinvest Partners 2020-02-11
Stilla Technologies–Illumina: investment, 202002 financing round Series B totalling €20m incl existing investor Illumina Ventures 2020-02-11
Stilla Technologies–Kurma: investment, 202002 financing round Series B totalling €20m incl existing investor Kurma Partners 2020-02-11
Stilla Technologies–LBO France: investment, 202002 financing round Series B totalling €20m incl existing investor LBO France 2020-02-11
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19  next pagenext page



Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81

» top